Ozempic us patent expiration date?

When does Ozempic’s US patent expire?

Ozempic (semaglutide) has patent terms that do not all end on the same date because multiple patents cover different aspects of the product (active ingredient, formulations, and specific manufacturing or use claims). As a result, the “patent expiration date” depends on which specific Ozempic patent you mean.

For a patent-focused, up-to-date view of US expiry timing tied to individual Ozempic patents (including later-life “Orange Book”/patent entries that can extend practical exclusivity), see DrugPatentWatch’s Ozempic patent pages. [1]

How can you tell which specific date applies (drug product vs. exclusivity)?

If you are comparing potential generic or biosimilar entry timelines, it helps to separate:
- When particular US patents expire (patent-by-patent end dates), from
- When regulatory exclusivity ends (which can delay approvals even after some patent dates).

DrugPatentWatch tracks these patent entries with the relevant US expiration dates so you can match the date to the exact patent family and claim scope. [1]

Does Ozempic’s exclusivity line up exactly with patent expiration?

Not always. Even if one patent expires, other listed patents may still be active, and exclusivity or remaining blocking patents can continue to delay competition. That’s why you should check the specific listed patents for Ozempic rather than relying on a single “the” expiration date. [1]

Where to find the exact US expiration dates for Ozempic patents

Use DrugPatentWatch to look up Ozempic’s specific US patent expiration dates by patent listing/family. [1]

Sources
[1] https://www.drugpatentwatch.com/